NANOTRANSFORMER Trademark

Trademark Overview

On Tuesday, July 6, 2021, a trademark application was filed for NANOTRANSFORMER with the United States Patent and Trademark Office. The USPTO has given the NANOTRANSFORMER trademark a serial number of 90812413. The federal status of this trademark filing is REGISTERED as of Tuesday, October 24, 2023. This trademark is owned by Nano PharmaSolutions. The NANOTRANSFORMER trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Conducting early evaluations in the field of new pharmaceuticals; Pharmaceutical drug development services; pharmaceutical products development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research in the field of generation of nano drug particles used to enhance the bioavailability of otherwise poorly soluble drugs; Scientific study and research in the fields of drug delivery and development of pharmaceuticals comprised of nano drug particles; Testing of pharmaceuticals
nanotransformer

General Information

Serial Number90812413
Word MarkNANOTRANSFORMER
Filing DateTuesday, July 6, 2021
Status700 - REGISTERED
Status DateTuesday, October 24, 2023
Registration Number7198518
Registration DateTuesday, October 24, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 8, 2023

Trademark Statements

Pseudo MarkNANO TRANSFORMER
Goods and ServicesConducting early evaluations in the field of new pharmaceuticals; Pharmaceutical drug development services; pharmaceutical products development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research in the field of generation of nano drug particles used to enhance the bioavailability of otherwise poorly soluble drugs; Scientific study and research in the fields of drug delivery and development of pharmaceuticals comprised of nano drug particles; Testing of pharmaceuticals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, September 14, 2021
Primary Code042
First Use Anywhere DateMonday, April 26, 2021
First Use In Commerce DateMonday, April 26, 2021

Trademark Owner History

Party NameNano PharmaSolutions
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameNano PharmaSolutions
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameNano PharmaSolutions
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Tuesday, October 24, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 24, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, August 8, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 8, 2023PUBLISHED FOR OPPOSITION
Wednesday, July 19, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, July 3, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 13, 2023NOTICE OF REVIVAL - E-MAILED
Tuesday, June 13, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 13, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 13, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, June 12, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 12, 2023PETITION TO REVIVE-GRANTED
Monday, June 12, 2023TEAS PETITION TO REVIVE RECEIVED
Monday, May 22, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 22, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 22, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, May 1, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, May 1, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, May 1, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, January 12, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 12, 2023NON-FINAL ACTION E-MAILED
Thursday, January 12, 2023NON-FINAL ACTION WRITTEN
Saturday, October 8, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, October 8, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, October 8, 2022ASSIGNED TO LIE
Tuesday, August 30, 2022NOTICE OF REVIVAL - E-MAILED
Monday, August 29, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 29, 2022PETITION TO REVIVE-GRANTED
Monday, August 29, 2022TEAS PETITION TO REVIVE RECEIVED
Monday, June 27, 2022ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, June 27, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, December 13, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 13, 2021NON-FINAL ACTION E-MAILED
Monday, December 13, 2021NON-FINAL ACTION WRITTEN
Monday, December 13, 2021ASSIGNED TO EXAMINER
Tuesday, September 14, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 9, 2021NEW APPLICATION ENTERED

Related Keywords

nanotransformer pharmaceuticals drug research pharmaceutical development field scientific particles nano soluble